Accelr8 Technology Corp (NYSEMKT:AXK)
CAPS Rating:
The Company intends to customize its technologies to the specific requirements of large licensees as well as develop new rapid pathogen detection assays.
Just Fool it
The Company intends to customize its technologies to the specific requirements of large licensees as well as develop new rapid pathogen detection assays.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
Solid financials support long-term technology development.